Simple method for quantitative analysis of N-linked glycoproteins in hepatocellular carcinoma specimens

Journal of Proteome Research

Volumn 9, Issue 1, 2010, Pages 308-318

  Lee, Hyoung Joo ^a   Na, Keun ^a   Choi, Eun Young ^a   Kim, Kyung Sik ^b   Kim, Hoguen ^b   Paik, Young Ki ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Exclude peak list; HCC; iTRAQ; N linked glycopeptides; Quantitative analysis

Indexed keywords

ANTITHROMBIN III; ASPARAGINE; GLYCOPEPTIDE; GLYCOPROTEIN; VITRONECTIN;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS;

AMINO ACID SEQUENCE; ANTITHROMBIN III; CARCINOMA, HEPATOCELLULAR; GLYCOPROTEINS; HUMANS; ISOTOPE LABELING; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL; VITRONECTIN;

EID: 73649124980     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900649b     Document Type: Article

References (46)

1. Dove, A. The bittersweet promise of glycobiology. Nat. Biotechnol. 2001, 19, 913-917.
2. Alavi, A.; Axford, J. S. Glyco-biomarkers: potential determinants of cellular physiology and pathology. Dis. Markers 2008, 25, 193-205.
3. Bosques, C. J.; Raguram, S.; Sasisekharan, R. The sweet side of biomarker discovery. Nat. Biotechnol. 2006, 24, 1100-1101.
4. Norton, P. A.; Comunale, M. A.; Krakover, J.; Rodemich, L.; et al. N-linked glycosylation of the liver cancer biomarker GP73. J. Cell. Biochem. 2008, 104, 136-149.
5. Kita, Y.; Miura, Y.; Furukawa, J.; Nakano, M.; et al. Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans. Mol. Cell. Proteomics 2007, 6, 1437-1445.
6. Drake, R. R.; Schwegler, E. E.; Malik, G.; Diaz, J.; et al. Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol. Cell. Proteomics 2006, 5, 1957-1967.
7. Kullolli, M.; Hancock, W. S.; Hincapie, M. Preparation of a highperformance multi-lectin affinity chromatography (HP-M-LAC) adsorbent for the analysis of human plasma glycoproteins. J. Sep. Sci. 2008, 31, 2733-2739.
8. Ito, H.; Kuno, A.; Sawaki, H.; Sogabe, M.; et al. Strategy for Glycoproteomics: Identification of Glyco-Alteration Using Multiple Glycan Profiling Tools (dagger). J. Proteome Res. 2009, 8, 1358-1367.
9. Madera, M.; Mechref, Y.; Klouckova, I.; Novotny, M. V. High-sensitivity profiling of glycoproteins from human blood serum through multiple-lectin affinity chromatography and liquid chromatography/ tandem mass spectrometry. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2007, 845, 121-137.
10. Kornfeld, R.; Kornfeld, S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 1985, 54, 631-664.
11. Yamashita, K.; Koide, N.; Endo, T.; Iwaki, Y.; Kobata, A. Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. J. Biol. Chem. 1989, 264, 2415-2423.
12. Cao, J.; Shen, C.; Wang, H.; Shen, H.; et al. Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach. J. Proteome Res. 2009, 8, 662-672.
13. Goldman, R.; Ressom, H. W.; Varghese, R. S.; Goldman, L.; et al. Detection of hepatocellular carcinoma using glycomic analysis. Clin. Cancer Res. 2009, 15, 1808-1813.
14. Na, K.; Lee, E. Y.; Lee, H. J.; Kim, K. Y.; Lee, H.; et al. Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma. Proteomics 2009, 9, 3989-3999.
15. Park, K. S.; Kim, H.; Kim, N. G.; Cho, S. Y.; et al. Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma. Hepatology 2002, 35, 1459-1466.
16. Park, K. S.; Cho, S. Y.; Kim, H.; Paik, Y. K. Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. Int. J. Cancer 2002, 97, 261-265.
17. Wuhrer, M.; Catalina, M. I.; Deelder, A. M.; Hokke, C. H. Glycoproteomics based on tandem mass spectrometry of glycopeptides. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2007, 849, 115-128.
18. Dalpathado, D. S.; Desaire, H. Glycopeptide Anal. Mass Spectrom. 2008, 133, 731-738.
19. Wada, Y.; Azadi, P.; Costello, C. E.; Dell, A.; et al. Comparison of the methods for profiling glycoprotein glycans - HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology 2007, 17, 411-422.
20. Lee, H. J.; Kang, M. J.; Lee, E. Y.; Cho, S. Y.; et al. Application of a peptide-based PF2D platform for quantitative proteomics in disease biomarker discovery. Proteomics 2008, 8, 3371-3381.
21. Cho, S. Y.; Lee, E. Y.; Lee, J. S.; Kim, H. Y.; et al. Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map. Proteomics 2005, 5, 3386-3396.
22. Cho, S. Y.; Lee, E. Y.; Kim, H. Y.; Kang, M. J.; et al. Protein profiling of human plasma samples by two-dimensional electrophoresis. Methods Mol. Biol. 2008, 428, 57-75.
23. Ashburner, M.; Ball, C. A.; Blake, J. A.; Botstein, D.; et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25, 25-29.
24. Seo, J.; Jeong, J.; Kim, Y. M.; Hwang, N.; et al. Strategy for comprehensive identification of post-translational modifications in cellular proteins, including low abundant modifications: application to glyceraldehyde-3-phosphate dehydrogenase. J. Proteome Res. 2008, 7, 587-602.
25. Rudomin, E. J.; Carr, S, A.; Jaffe, J, D. Directed sample interrogation utilizing an accurate mass exclusion-based data-dependent acquisition strategy (AMEx). J. Proteome Res. 2009, 8, 3154-3160.
26. Schwudke, D.; Liebisch, G.; Herzog, R.; Schmitz, G.; Shevchenko, A. Shotgun lipidomics by tandem mass spectrometry under data-dependent acquisition control. Methods Enzymol. 2007, 433, 175-191.
27. Chen, X.; Sun, L.; Yu, Y.; Xue, Y.; Yang, P. Amino acid-coded tagging-based approaches in quantitative proteomics. Expert Rev. Proteomics 2007, 4, 25-37.
28. Zhao, Y.; Lee, W. N.; Xiao, G. G. Quantitative proteomics and biomarker discovery in human cancer. Expert Rev. Proteomics 2009, 6, 115-118.
29. Lee, H. J.; Lee, E. Y.; Kwon, M. S.; Paik, Y. K. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics. Curr. Opin. Chem. Biol. 2006, 10, 42-49.
30. Zhang, H.; Liu, A. Y.; Loriaux, P.; Wollscheid, B.; et al. Mass spectrometric detection of tissue proteins in plasma. Mol. Cell Proteomics 2007, 6, 64-71.
31. Lau, S. H.; Sham, J. S.; Xie, D.; Tzang, C. H.; et al. Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene 2006, 25, 1242-1250.
32. Paradis, V.; Degos, F.; Dargère, D.; Pham, N.; et al. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 2005, 41, 40-47.
33. Lee, H. J.; Na, K.; Kwon, M. S.; Kim, H. G.; Kim, K. S.; Paik, Y. K. Quantitative analysis of phosphopeptides in search of the disease biomarker from the hepatocellular carcinoma specimen. Proteomics 2009, 12, 3395-3408.
34. Kang, Y. K.; Hong, S. W.; Lee, H.; Kim, W. H. Overexpression of clusterin in human hepatocellular carcinoma. Hum. Pathol. 2004, 35, 1340-1346.
35. Edwards, S.; Lalor, P. F.; Tuncer, C.; Adams, D. H. Vitronectin in human hepatic tumours contributes to the recruitment of lymphocytes in an alpha v beta3-independent manner. Br. J. Cancer 2006, 95, 1545-1554.
36. Helenius, A.; Aebi, M. Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 2004, 73, 1019-1049.
37. Sano, K.; Asanuma-Date, K.; Arisaka, F.; Hattori, S.; Ogawa, H. Changes in glycosylation of vitronectin modulate multimerization and collagen binding during liver regeneration. Glycobiology 2007, 17, 784-794.
38. Nejjari, M.; Hafdi, Z.; Gouysse, G.; Fiorentino, M.; et al. Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study. Hepatology 2002, 36, 418-426.
39. Irungu, J.; Go, E. P.; Dalpathado, D. S.; Desaire, H. Simplification of mass spectral analysis of acidic glycopeptides using GlycoPep ID. Anal. Chem. 2007, 79, 3065-3074.
40. Ogawa, H.; Yoneda, A.; Seno, N.; Hayashi, M.; et al. Structures of the N-linked oligosaccharides on human plasma vitronectin. Eur. J. Biochem. 1995, 230, 994-1000.
41. Wrann, M. Methylation analysis of the carbohydrate portion of fibronectin isolated from human plasma. Biochem. Biophys. Res. Commun. 1978, 84, 269-274.
42. Kam, R. K.; Poon, T. C.; Chan, H. L.; Wong, N.; et al. High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis. Clin. Chem 2007, 53, 1254-1263.
43. Samonakis, D. N.; Koutroubakis, I. E.; Sfiridaki, A.; Malliaraki, N.; et al. Hypercoagulable states in patients with hepatocellular carcinoma. Dig. Dis. Sci. 2004, 49, 854-858.
44. Al Ghumlas, A. K.; Abdel Gader, A. G.; Al Faleh, F. Z. Haemostatic abnormalities in liver disease: could some haemostatic tests be useful as liver function tests? Blood Coagul. Fibrinolysis 2005, 16, 329-335.
45. Zhang, H.; Li, X. J.; Martin, D. B.; Aebersold, R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 6, 660-666.
46. Yang, Z.; Harris, L. E.; Palmer-Toy, D. E.; Hancock, W. S. Multilectin affinity chromatography for characterization of multiple glycoprotein biomarker candidates in serum from breast cancer patients. Clin. Chem. 2006, 52, 1897-1905.